These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31079534)

  • 21. The case for uricase in gout.
    Pay S; Terkeltaub AR
    Curr Rheumatol Rep; 2003 Jun; 5(3):213-4. PubMed ID: 12744813
    [No Abstract]   [Full Text] [Related]  

  • 22. Pegloticase (krystexxa) for treatment of refractory gout.
    Med Lett Drugs Ther; 2011 Feb; 53(1357):9-10. PubMed ID: 21304442
    [No Abstract]   [Full Text] [Related]  

  • 23. A radiochemical-high-performance liquid chromatographic assay for urate oxidase in human plasma.
    Greenberg ML; Hershfield MS
    Anal Biochem; 1989 Feb; 176(2):290-3. PubMed ID: 2742121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout.
    Tan PK; Farrar JE; Gaucher EA; Miner JN
    Mol Biol Evol; 2016 Sep; 33(9):2193-200. PubMed ID: 27352852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
    Dalbeth N; Doyle AJ; McQueen FM; Sundy J; Baraf HS
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):82-5. PubMed ID: 23836458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypouricaemic effect after oral administration in chickens of polyethylene glycol-modified uricase entrapped in liposomes.
    Nishida Y; Kamatani N; Miyamoto T
    J Pharm Pharmacol; 1984 May; 36(5):354-5. PubMed ID: 6145782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel drug discovery strategies for gout.
    Richette P; Garay R
    Expert Opin Drug Discov; 2013 Feb; 8(2):183-9. PubMed ID: 23231400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case Report of Immunosuppressant Medication‒Associated Polyarticular Tophaceous Gout Successfully Treated Using the Polyethylene Glycol‒Conjugated Uricase Enzyme Pegloticase.
    Freyne B
    Transplant Proc; 2018 Dec; 50(10):4099-4101. PubMed ID: 30577324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of chronic refractory tophaceous gout with erosions with pegloticase.
    Yeter KC; Ortiz EC; Arkfeld DG
    Int J Rheum Dis; 2013 Jun; 16(3):369-70. PubMed ID: 23981765
    [No Abstract]   [Full Text] [Related]  

  • 31. A new practical system for evaluating the pharmacological properties of uricase as a potential drug for hyperuricemia.
    Feng J; Li X; Yang X; Zhang C; Yuan Y; Pu J; Zhao Y; Xie Y; Yuan H; Bu Y; Liao F
    Arch Pharm Res; 2010 Nov; 33(11):1761-9. PubMed ID: 21116779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolution of gouty tophi after twelve weeks of pegloticase treatment.
    Baraf HS; Matsumoto AK; Maroli AN; Waltrip RW
    Arthritis Rheum; 2008 Nov; 58(11):3632-4. PubMed ID: 18975338
    [No Abstract]   [Full Text] [Related]  

  • 33. Immobilized-enzyme nylon-tube reactor for routine determination of uric acid in serum.
    Sundaram PV; Igloi MP; Wassermann R; Hinsch W
    Clin Chem; 1978 Oct; 24(10):1813-7. PubMed ID: 699291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gout therapeutics: new drugs for an old disease.
    Burns CM; Wortmann RL
    Lancet; 2011 Jan; 377(9760):165-77. PubMed ID: 20719377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of tea and coffee consumption on serum uric acid levels by liquid-chromatographic and uricase methods.
    Yuan SC; Wang CJ; Kuo HW; Maa MC; Hsieh YS
    Bull Environ Contam Toxicol; 2000 Sep; 65(3):300-6. PubMed ID: 10903352
    [No Abstract]   [Full Text] [Related]  

  • 36. Pegloticase: a novel agent for treatment-refractory gout.
    Shannon JA; Cole SW
    Ann Pharmacother; 2012 Mar; 46(3):368-76. PubMed ID: 22395256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking.
    Modjinou DV; Krasnokutsky S; Gyftopoulos S; Pike VC; Karis E; Keenan RT; Lee K; Crittenden DB; Samuels J; Pillinger MH
    Clin Rheumatol; 2017 Sep; 36(9):2101-2107. PubMed ID: 28623421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.
    Bomalaski JS; Clark MA
    Curr Rheumatol Rep; 2004 Jun; 6(3):240-7. PubMed ID: 15134605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout.
    Yue CS; Huang W; Alton M; Maroli AN; Waltrip RW; Wright D; Marco MD
    J Clin Pharmacol; 2008 Jun; 48(6):708-18. PubMed ID: 18420531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach.
    Tiwari S; Dwivedi H; Kymonil KM; Saraf SA
    Drug Deliv Transl Res; 2015 Jun; 5(3):219-30. PubMed ID: 25787730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.